Hongkai Zhang
Shandong University(CN)Beijing Technology and Business University(CN)Capital Medical University(CN)Chinese Center For Disease Control and Prevention(CN)Hebei University of Technology(CN)Nankai University(CN)Tianjin First Center Hospital(CN)ShanghaiTech University(CN)Wuhan University(CN)Beijing Anzhen Hospital(CN)Henan Cancer Hospital(CN)Beijing Hospital of Traditional Chinese Medicine(CN)Tianjin Medical University(CN)Wuhan Institute of Technology(CN)
Publications by Year
Research Areas
CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Virus-based gene therapy research, SARS-CoV-2 and COVID-19 Research, Immune Cell Function and Interaction
Most-Cited Works
- → Magnetic and pH-responsive nanocarriers with multilayer core–shell architecture for anticancer drug delivery(2008)115 cited
- → High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics(2021)108 cited
- → A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes(2021)103 cited
- → Structures of Omicron spike complexes and implications for neutralizing antibody development(2022)64 cited
- → An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ(2022)57 cited
- → Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma(2020)57 cited